Post/November 11, 2026Glanzmann thrombasthenia has no approved preventive treatment. A weekly injection enters its final-stage trialNo preventive Glanzmann thrombasthenia treatment is approved. Hemab has opened SOLARA, a pivotal trial of sutacimig, a once-weekly injection.HNHealthcare News·November 11, 2026
